Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis

The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor and HER2 expression in invasive breast carcinoma

(2012) Isil Z Yildiz-Aktas et al.   MODERN PATHOLOGY

Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing?

(2011) K. H. Allison et al.   BREAST CANCER RESEARCH AND TREATMENT

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score

(2011) S Sahebjam et al.   BRITISH JOURNAL OF CANCER

Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors

(2011) Gong Tang et al.   JOURNAL OF CLINICAL ONCOLOGY

High False-Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study

(2011) David J. Dabbs et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

(2011) Jack Cuzick et al.   JOURNAL OF CLINICAL ONCOLOGY

A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas

(2011) Geza Acs et al.   MODERN PATHOLOGY

The Oncotype DX Recurrence Score Is Correlated With a Composite Index Including Routinely Reported Pathobiologic Features

(2010) Joseph Geradts et al.   CANCER INVESTIGATION

A Lower Allred Score for Progesterone Receptor Is Strongly Associated With a Higher Recurrence Score of 21-Gene Assay in Breast Cancer

(2010) Ping Tang et al.   CANCER INVESTIGATION

Impact of biospecimens handling on biomarker research in breast cancer

(2009) Loris De Cecco et al.   BMC CANCER

Complementary Value of the Ki-67 Proliferation Index to the Oncotype DX Recurrence Score

(2009) Katja Gwin et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Histopathologic variables predict Oncotype DX™ Recurrence Score

(2008) Melina B Flanagan et al.   MODERN PATHOLOGY